Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.
D000284:Administration, Oral; D001645:Biguanides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D050260:Carbohydrate Metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003919:Diabetes Insipidus / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000078790:Insulin Secretion; D007700:Kinetics; D008055:Lipids / Q000097:blood; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013961:Thyroid Gland / Q000187:drug effects
D001645:Biguanides; D007328:Insulin; D008055:Lipids; D013453:Sulfonylurea Compounds